ES2548653R1 - METHOD AND KIT FOR THE CELIAQUIA DIAGNOSIS - Google Patents

METHOD AND KIT FOR THE CELIAQUIA DIAGNOSIS Download PDF

Info

Publication number
ES2548653R1
ES2548653R1 ES201430567A ES201430567A ES2548653R1 ES 2548653 R1 ES2548653 R1 ES 2548653R1 ES 201430567 A ES201430567 A ES 201430567A ES 201430567 A ES201430567 A ES 201430567A ES 2548653 R1 ES2548653 R1 ES 2548653R1
Authority
ES
Spain
Prior art keywords
diagnosis
kit
celiaquia
genetic markers
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201430567A
Other languages
Spanish (es)
Other versions
ES2548653B1 (en
ES2548653A2 (en
Inventor
Mª Concepción NÚÑEZ PARDO DE VERA
Andrés BODAS PINEDO
Natalia LÓPEZ PALACIOS
Romina DIELI CRIMI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos
Original Assignee
Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos filed Critical Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos
Priority to ES201430567A priority Critical patent/ES2548653B1/en
Publication of ES2548653A2 publication Critical patent/ES2548653A2/en
Publication of ES2548653R1 publication Critical patent/ES2548653R1/en
Application granted granted Critical
Publication of ES2548653B1 publication Critical patent/ES2548653B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Método y kit para el diagnóstico de celiaquía.#La presente invención se refiere a métodos y kits para el diagnóstico de la enfermedad celíaca mediante la combinación mediante un único kit de la detección de marcadores serológicos y genéticos. La presente invención pone de manifiesto que la presencia de anticuerpos frente a neoepítopos que surgen de la unión del complejo transglutaminasa tipo 2-péptidos deamidados de gliadina y la ausencia de los marcadores genéticos HLA-DQ2 o -DQ8, puede indicar la presencia de la enfermedad.Method and kit for the diagnosis of celiac disease # The present invention relates to methods and kits for the diagnosis of celiac disease by combining it with a single kit for the detection of serological and genetic markers. The present invention shows that the presence of antibodies against neoepitopes that arise from the union of the transglutaminase complex type 2-deamidated peptides of gliadin and the absence of the genetic markers HLA-DQ2 or -DQ8, may indicate the presence of the disease .

ES201430567A 2014-04-16 2014-04-16 METHOD AND KIT FOR THE CELIAQUIA DIAGNOSIS Expired - Fee Related ES2548653B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201430567A ES2548653B1 (en) 2014-04-16 2014-04-16 METHOD AND KIT FOR THE CELIAQUIA DIAGNOSIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201430567A ES2548653B1 (en) 2014-04-16 2014-04-16 METHOD AND KIT FOR THE CELIAQUIA DIAGNOSIS

Publications (3)

Publication Number Publication Date
ES2548653A2 ES2548653A2 (en) 2015-10-19
ES2548653R1 true ES2548653R1 (en) 2015-12-30
ES2548653B1 ES2548653B1 (en) 2017-01-18

Family

ID=54292291

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201430567A Expired - Fee Related ES2548653B1 (en) 2014-04-16 2014-04-16 METHOD AND KIT FOR THE CELIAQUIA DIAGNOSIS

Country Status (1)

Country Link
ES (1) ES2548653B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2759342C1 (en) * 2020-12-03 2021-11-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный педиатрический медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПбГПМУ Минздрава России) Method for diagnosing autoimmune gastritis in children with celiac disease

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BONAMICO MARGHERITA et al. Serologic and genetic markers of celiac disease: A sequential study in the screening of first degree relatives.JPGN Journal of Pediatric Gastroenterology and Nutrition FEB 2006 00/02/2006 VOL: 42 No: 2 Pags: 150-154 ISSN 0277-2116 todo el documento. *
FRANK KNEEPKENS C M et al. Clinical practice ; Coeliac disease.European Journal of Pediatrics, 20120316 Springer, Berlin, DE 16/03/2012 VOL: 171 No: 7 Pags: 1011 - 1021 ISSN 1432-1076 Doi: doi:10.1007/s00431-012-1714-8 todo el documento. *
MEGIORNI F et al. HLA-DQ and risk gradient for celiac disease.HUMAN IMMUNOLOGY, 20090101 NEW YORK, NY, US 01/01/2009 VOL: 70 No: 1 Pags: 55 - 59 ISSN 0198-8859 Doi: doi:10.1016/j.humimm.2008.10.018 Monos Dimitri; Maiers Martin J todo el documento. *
PARTANEN JUKKA et al. HLA in coeliac disease patients not carrying the DQA1*05 DQB1*02 heterodimer: Results from the European genetics cluster on coeliac disease..Genes and Immunity May 2003 00/05/2003 VOL: 4 No: Supplement 1 Pags: S6 ISSN 1466-4879 (ISSN print) todo el documento. *
PIETZAK M M ET AL. Stratifying Risk for Celiac Disease in a Large At-Risk United States Population by Using HLA Alleles.CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 20090901 AMERICAN GASTROENTEROLOGICAL ASSOCIATION, US 01/09/2009 VOL: 7 No: 9 Pags: 966 - 971 ISSN 1542-3565 Doi: doi:10.1016/j.cgh.2009.05.028 todo el documento. *

Also Published As

Publication number Publication date
ES2548653B1 (en) 2017-01-18
ES2548653A2 (en) 2015-10-19

Similar Documents

Publication Publication Date Title
HRP20190026T1 (en) Assays for detecting the presence or amount of an anti-drug antibody
ECSP18000844A (en) TAU UNION ANTIBODIES
CO2017006740A2 (en) Anti-cd79b antibodies
CL2018000595A1 (en) Anti-PD1 antibodies and methods of use
BR112016022727A8 (en) claudin-6 specific immunoreceptors and t-cell epitopes
EA201791029A1 (en) ANTIBODIES AGAINST INTERLEUKIN-33 AND THEIR APPLICATION
CR20170297A (en) METHOD FOR THE ABSOLUTE QUANTIFICATION OF CANCER PEPTIDES RESTRICTED TO HLA THAT ARE PROCESSED NATURAL
GT201700112A (en) HETERODIMERIC ANTIBODIES THAT JOIN CD3 AND TUMOR ANTIGENS
MA40682A (en) ANTI-OX40 ANTIBODIES AND CORRESPONDING METHODS OF USE
EA201691610A8 (en) ANTI-JAGGED1 ANTIBODIES AND METHODS OF APPLICATION
CL2017001461A1 (en) Compositions and methods for antibodies that are labeled bmp6
WO2015187018A3 (en) Means and methods for determining t cell recognition
NZ742911A (en) Peptide microarrays and novel biomarkers for celiac disease
UY36187A (en) ALFA AND OMEGA INTERFER ANTAGONIST ANTIBODIES
MX2017004516A (en) Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease.
EA202091497A2 (en) GENETIC LOCUS ASSOCIATED WITH INCREASED FERTILITY IN MAIS
BR112017000179A2 (en) analysis of displacement parts for selection of candidate lines for seismic surveys.
ES2548653R1 (en) METHOD AND KIT FOR THE CELIAQUIA DIAGNOSIS
AR104413A1 (en) IGF-1R ANTIBODY AND ITS USE TO DIAGNOSTIC CANCER
GB201711189D0 (en) Determining the hydrocarbon plus fraction of a sample separated by gas chromatography
AP2016009462A0 (en) Qualitative predictive method for differential diagnosis of pneumococcic, meningococcic and viral menigitis, differential meningitis diagnostic method and kit
PL408620A1 (en) Method for the set for detecting leucaemic cells resistant to deltanoids and the antibody used in it
CR20150081A (en) THE DETECTION OF A SPECIFIC PATHOGEN FUNG
TH1601003614A (en) Improved diagnostic test for CSFV antibodies
TH1501006572B (en) Diagnostic test kit for pithiosis in humans and animals By means of immunochromatography.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2548653

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20170118

FD2A Announcement of lapse in spain

Effective date: 20220630